ZA944187B - Ipsapirone medicament formulation - Google Patents

Ipsapirone medicament formulation

Info

Publication number
ZA944187B
ZA944187B ZA944187A ZA944187A ZA944187B ZA 944187 B ZA944187 B ZA 944187B ZA 944187 A ZA944187 A ZA 944187A ZA 944187 A ZA944187 A ZA 944187A ZA 944187 B ZA944187 B ZA 944187B
Authority
ZA
South Africa
Prior art keywords
ipsapirone
medicament formulation
medicament
formulation
ipsapirone medicament
Prior art date
Application number
ZA944187A
Other languages
English (en)
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Guenter Schoellnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA944187B publication Critical patent/ZA944187B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
ZA944187A 1993-06-15 1994-06-14 Ipsapirone medicament formulation ZA944187B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (de) 1993-06-15 1993-06-15 Ipsapiron Arzneimittelzubereitung

Publications (1)

Publication Number Publication Date
ZA944187B true ZA944187B (en) 1995-02-08

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944187A ZA944187B (en) 1993-06-15 1994-06-14 Ipsapirone medicament formulation

Country Status (16)

Country Link
EP (1) EP0629402A1 (ja)
JP (1) JPH06345649A (ja)
KR (1) KR950000150A (ja)
CN (1) CN1099263A (ja)
AU (1) AU6345794A (ja)
CA (1) CA2125620A1 (ja)
CZ (1) CZ146494A3 (ja)
DE (1) DE4319760A1 (ja)
FI (1) FI942803A (ja)
HU (1) HUT70759A (ja)
IL (1) IL109993A0 (ja)
NO (1) NO942228L (ja)
NZ (1) NZ260732A (ja)
PL (1) PL303822A1 (ja)
SK (1) SK72494A3 (ja)
ZA (1) ZA944187B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
DK1140105T3 (da) * 1998-12-24 2004-02-23 Janssen Pharmaceutica Nv Galantaminpræparat med styret frigivelse
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
CN114727995A (zh) * 2020-09-02 2022-07-08 北京华昊中天生物医药股份有限公司 优替德隆的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386440B1 (de) * 1989-02-11 1992-08-05 Bayer Ag Arzneimittel mit kontrollierter Wirkstoffabgabe
DD297767A5 (de) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De Arzneimittel mit kontrollierter wirkstoffabgabe
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤

Also Published As

Publication number Publication date
HU9401771D0 (en) 1994-09-28
NZ260732A (en) 1996-02-27
AU6345794A (en) 1994-12-22
IL109993A0 (en) 1994-10-07
SK72494A3 (en) 1995-04-12
EP0629402A1 (de) 1994-12-21
JPH06345649A (ja) 1994-12-20
NO942228L (no) 1994-12-16
CA2125620A1 (en) 1994-12-16
FI942803A (fi) 1994-12-16
CZ146494A3 (en) 1995-01-18
FI942803A0 (fi) 1994-06-13
DE4319760A1 (de) 1994-12-22
CN1099263A (zh) 1995-03-01
KR950000150A (ko) 1995-01-03
PL303822A1 (en) 1995-01-09
HUT70759A (en) 1995-10-30
NO942228D0 (no) 1994-06-14

Similar Documents

Publication Publication Date Title
IL102777A0 (en) Pharmaceutical combination formulation
GB9402203D0 (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9114950D0 (en) Pharmaceutical formulation
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
ZA944187B (en) Ipsapirone medicament formulation
GB9216061D0 (en) Pharmaceutical combination formulation
GB2258613B (en) Pharmaceutical diltiazem formulation
GB9418550D0 (en) Drug formulation
ZA945962B (en) Therapeutic formulation
GB9323487D0 (en) Therapeutic formulation
GB9322906D0 (en) Pharmaceutical formulation
GB9322907D0 (en) Pharmaceutical formulation
GB9316250D0 (en) Pharmaceutical formulation
GB9305437D0 (en) Pharmaceutical formulation
GB9305439D0 (en) Pharmaceutical formulation
GB9321346D0 (en) Pharmaceutical formulation
GB9315016D0 (en) Pharmaceutical formulation
GB9316253D0 (en) Pharmaceutical formulation
GB9312705D0 (en) Pharmaceutical formulation
GB9122115D0 (en) Pharmaceutical formulation
GB9116467D0 (en) Pharmaceutical formulation
GB9121798D0 (en) Pharmaceutical formulation
GB9112974D0 (en) Pharmaceutical formulation